MEGIN
  • About us
  • MEG Maps™
    • What is MEG Maps™
    • Book a MEG Maps™ Demo
  • News & Education
    • News
    • MEGIN Spotlights
    • MEGIN Masterclass
    • Abstracts & Studies
  • Patients
  • Find a MEG site
    • Global
    • North America
  • Get in touch
    • Contact us
    • Book a MEG Maps™ Demo
    • MEGIN Community
  • 🇨🇳
Select Page
MEG in neuro-oncology: translating from cells to networks to clinical care

MEG in neuro-oncology: translating from cells to networks to clinical care

by MEGIN | Dec 4, 2024 | Masterclass - Clinical MEG

Presented by Amsterdam...
ACMEGS- The 10 Common Evidence-Supported Indications for MEG in Epilepsy Surgery

ACMEGS- The 10 Common Evidence-Supported Indications for MEG in Epilepsy Surgery

by MEGIN | Apr 8, 2024 | Masterclass - Clinical MEG

Presented by Anto I. Bagić, MD, PhD, FAES, FACNS, Jeffrey R. Tenney, MD, PhD, FACNS, and Andrew J. Zillgitt, DO, FAES,...
Individualized EEG/MEG targeted and optimized multi-channel transcranial electric stimulation in focal epilepsy

Individualized EEG/MEG targeted and optimized multi-channel transcranial electric stimulation in focal epilepsy

by MEGIN | Mar 19, 2024 | Masterclass - Clinical MEG

Presented by Prof. Dr. rer. nat. Carsten H....
Magnetoencephalography (MEG) in clinical practice

Magnetoencephalography (MEG) in clinical practice

by MEGIN | Feb 29, 2024 | Masterclass - Clinical MEG

Presented by Dr. Vahe...
Electromagnetic Source Imaging in the Presurgical Evaluation of Children with Drug Resistant Epilepsy

Electromagnetic Source Imaging in the Presurgical Evaluation of Children with Drug Resistant Epilepsy

by MEGIN | Oct 22, 2022 | Masterclass - Clinical MEG

Presented by Dr. Christos...
Guidelines and practical considerations for language mapping in clinical cohorts using magnetoencephalography (MEG)

Guidelines and practical considerations for language mapping in clinical cohorts using magnetoencephalography (MEG)

by MEGIN | Sep 30, 2022 | Masterclass - Clinical MEG

Presented by Dr. Roozbeh...
« Older Entries

Subscribe to MEGIN Matters

Don't miss the latest MEG insights and MEGIN news - complete the form below to be added to our mailing list and receive MEGIN Matters right in your inbox!

Join Our Mailing List

Home
About us

MEG Maps™
Careers
Contact us
Join Our Mailing List

Insights & education
News
MEGIN Spotlights
MEGIN Masterclass
Abstracts & studies

MEGIN Community

Patients

Find a MEG site
Global
North America

Connect with us
  • Follow
  • Follow
  • Follow

Copyright 2025© – MEGIN
MEGIN’s new platform MEG Maps™ is powered by TRIUX™ neo and MEGreview™, which have 510(k) clearance from the US Food & Drug Administration (FDA) and are under EU MDR Notified body review, i.e. not available for commercial distribution in the EU area. For commercial distribution, please contact your local MEGIN representative. TRIUX™ neo is intended to non-invasively record brain activity, and when interpreted by trained physicians, to help localize these active areas. All other applications are scientific research in nature. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician
.

Subscribe to MEGIN Matters

Don’t miss the latest MEG insights and MEGIN news – complete the form below to be added to our mailing list and receive MEGIN Matters right in your inbox!